Literature DB >> 30409707

History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.

Ravi B Patel1, Muthiah Vaduganathan2, Aruna Rikhi3, Hrishikesh Chakraborty3, Stephen J Greene4, Adrian F Hernandez4, G Michael Felker4, Margaret M Redfield5, Javed Butler6, Sanjiv J Shah7.   

Abstract

OBJECTIVES: This study sought to characterize the course of decongestion among patients hospitalized for acute heart failure (AHF) by history of atrial fibrillation (AF) and/or atrial flutter (AFL).
BACKGROUND: AF/AFL and chronic heart failure (HF) commonly coexist. Little is known regarding the impact of AF/AFL on relief of congestion among patients who develop AHF.
METHODS: We pooled patients from 3 randomized trials of AHF conducted within the Heart Failure Network, the DOSE (Diuretic Optimization Strategies) trial, the ROSE (Renal Optimization Strategies) trial, and the CARRESS-HF (Cardiorenal Rescue Study in Acute Decompensated Heart Failure) trial. The association between history of AF/AFL and in-hospital changes in various metrics of congestion was assessed using covariate-adjusted linear and ordinal logistic regression models.
RESULTS: Of 750 unique patients, 418 (56%) had a history of AF/AFL. Left ventricular ejection fraction was higher (35% vs. 27%, respectively; p < 0.001), and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were nonsignificantly lower at baseline (4,210 pg/ml vs. 5,037 pg/ml, respectively; p = 0.27) in patients with AF/AFL. After adjustment of covariates, history of AF/AFL was associated with less substantial loss of weight (-5.7% vs. -6.5%, respectively; p = 0.02) and decrease in NT-proBNP levels (-18.7% vs. -31.3%, respectively; p = 0.003) by 72 or 96 h. History of AF/AFL was also associated with a blunted increase in global sense of well being at 72 or 96 h (p = 0.04). There was no association between history of AF/AFL and change in orthodema congestion score (p = 0.67) or 60-day composite clinical endpoint (all-cause mortality or any rehospitalization; hazard ratio: 1.21; 95% confidence interval: 0.92 to 1.59; p = 0.17).
CONCLUSIONS: More than half of the patients admitted with AHF had a history of AF/AFL. History of AF/AFL was independently associated with a blunted course of in-hospital decongestion. Further research is required to understand the utility of specific therapies targeting AF/AFL during hospitalization for AHF.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; atrial flutter; body weight; decongestion; heart failure

Mesh:

Substances:

Year:  2018        PMID: 30409707      PMCID: PMC6320310          DOI: 10.1016/j.jchf.2018.09.008

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  34 in total

1.  Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.

Authors:  Stephen J Greene; Gregg C Fonarow; Scott D Solomon; Haris P Subacius; Andrew P Ambrosy; Muthiah Vaduganathan; Aldo P Maggioni; Michael Böhm; Eldrin F Lewis; Faiez Zannad; Javed Butler; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2016-10-17       Impact factor: 15.534

2.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

3.  Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).

Authors:  Andrew P Ambrosy; Ankeet S Bhatt; Dianne Gallup; Kevin J Anstrom; Javed Butler; Adam D DeVore; G Michael Felker; Marat Fudim; Stephen J Greene; Adrian F Hernandez; Jacob P Kelly; Marc D Samsky; Robert J Mentz
Journal:  Am J Cardiol       Date:  2017-04-12       Impact factor: 2.778

Review 4.  Atrial fibrillation in heart failure with preserved ejection fraction: Insights into mechanisms and therapeutics.

Authors:  Ravi B Patel; Muthiah Vaduganathan; Sanjiv J Shah; Javed Butler
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

Review 5.  The war against heart failure: the Lancet lecture.

Authors:  Eugene Braunwald
Journal:  Lancet       Date:  2014-11-16       Impact factor: 79.321

6.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

7.  Catheter Ablation for Atrial Fibrillation with Heart Failure.

Authors:  Nassir F Marrouche; Johannes Brachmann; Dietrich Andresen; Jürgen Siebels; Lucas Boersma; Luc Jordaens; Béla Merkely; Evgeny Pokushalov; Prashanthan Sanders; Jochen Proff; Heribert Schunkert; Hildegard Christ; Jürgen Vogt; Dietmar Bänsch
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

8.  Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.

Authors:  Maja Cikes; Brian Claggett; Amil M Shah; Akshay S Desai; Eldrin F Lewis; Sanjiv J Shah; Inder S Anand; Eileen O'Meara; Jean L Rouleau; Nancy K Sweitzer; James C Fang; Sanjeev Saksena; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2018-07-11       Impact factor: 12.035

9.  Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.

Authors:  Robert J Mentz; Matthew J Chung; Mihai Gheorghiade; Peter S Pang; Mary J Kwasny; Andrew P Ambrosy; Muthiah Vaduganathan; Christopher M O'Connor; Karl Swedberg; Faiez Zannad; Marvin A Konstam; Aldo P Maggioni
Journal:  Am Heart J       Date:  2012-10-29       Impact factor: 4.749

10.  Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.

Authors:  Seraj Abualnaja; Mohua Podder; Adrian F Hernandez; John J V McMurray; Randall C Starling; Christopher M O'Connor; Robert M Califf; Paul W Armstrong; Justin A Ezekowitz
Journal:  J Am Heart Assoc       Date:  2015-08-24       Impact factor: 5.501

View more
  6 in total

Review 1.  Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes.

Authors:  Aakash Bavishi; Ravi B Patel
Journal:  Heart Fail Clin       Date:  2020-07-21       Impact factor: 3.179

2.  Association of the H2FPEF Risk Score with Recurrence of Atrial Fibrillation Following Pulmonary Vein Isolation.

Authors:  Ravi B Patel; Caitlin Somerville; Fei Fei Gong; Andrew C Peters; Sanjiv J Shah; Alexandru B Chicos; Susan Kim; Bradley P Knight; Albert Lin; Nishant Verma; Rod S Passman
Journal:  J Atr Fibrillation       Date:  2020-04-30

3.  In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients With Heart Failure Exacerbation and Atrial Fibrillation: A Cross-Sectional Study.

Authors:  Karthik Gangu; Aniesh Bobba; Harleen Kaur Chela; Sindhu Avula; Sanket Basida; Neha Yadav
Journal:  Int J Heart Fail       Date:  2022-07-20

4.  Clinical characteristics and in-hospital outcomes of acute decompensated heart failure patients with and without atrial fibrillation.

Authors:  Umut Kocabaş; Ümit Yaşar Sinan; Emre Aruğaslan; Mustafa Kurşun; Ali Çoner; Özlem Özcan Çelebi; Cengiz Öztürk; Onur Dalgıç; Ebru Ipek Türkoğlu; Hatice Soner Kemal; Emine Gazi; Cihan Altın; Mehdi Zoghi
Journal:  Anatol J Cardiol       Date:  2020-04       Impact factor: 1.596

5.  Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure.

Authors:  Kenji Yoshioka; Daichi Maeda; Takahiro Okumura; Keisuke Kida; Shogo Oishi; Eiichi Akiyama; Satoshi Suzuki; Masayoshi Yamamoto; Akira Mizukami; Shunsuke Kuroda; Nobuyuki Kagiyama; Tetsuo Yamaguchi; Tetsuo Sasano; Akihiko Matsumura; Takeshi Kitai; Yuya Matsue
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

Review 6.  Heart failure and atrial flutter: a systematic review of current knowledge and practices.

Authors:  Michael J Diamant; Jason G Andrade; Sean A Virani; Pardeep S Jhund; Mark C Petrie; Nathaniel M Hawkins
Journal:  ESC Heart Fail       Date:  2021-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.